Cargando…
Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice.
Significant low density lipoprotein (LDL) uptake by tumour cells led to the use of LDL as a discriminatory vehicle for the delivery of cytotoxic drugs. In the current study, the lipophilic elliptinium derivative, elliptinium-oleate (OL-NME), was incorporated into LDL to reach an incorporation level...
Autores principales: | Samadi-Baboli, M., Favre, G., Canal, P., Soula, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968583/ https://www.ncbi.nlm.nih.gov/pubmed/8347487 |
Ejemplares similares
-
Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice.
por: Versluis, A. J., et al.
Publicado: (1996) -
Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2010) -
Characterization of a very-low-density lipoprotein (VLDL)-associated cytotoxic factor.
por: Chan, S. Y., et al.
Publicado: (1981) -
Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.
por: Versluis, A. J., et al.
Publicado: (1998) -
Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative.
por: Allison, B. A., et al.
Publicado: (1994)